Back
iShares iBonds Dec 2026 Term Corporate ETF Vs. Collegium Pharmaceutical Industry Stock Comparison
Buy
64
IBDR
iShares iBonds Dec 2026 Term Corporate ETF
Last Price:
$24.08
Seasonality Move:
-1.49%
Sell
45
COLL
Collegium Pharmaceutical
Last Price:
$33.33
Seasonality Move:
-1.63%
Buy
64
iShares iBonds Dec 2026 Term Corporate ETF (IBDR)
is a Buy
Is iShares iBonds Dec 2026 Term Corporate ETF a Buy, Sell or Hold?
-
The current iShares iBonds Dec 2026 Term Corporate ETF [IBDR] share price is $24.07. The Score for IBDR is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
IBDR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Collegium Pharmaceutical (COLL)
is a Sell
Is Collegium Pharmaceutical a Buy, Sell or Hold?
-
The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IBDR Stock Price Chart
What is iShares iBonds Dec 2026 Term Corporate ETF's stock price today?
-
The iShares iBonds Dec 2026 Term Corporate ETF share price today is $24.07The current trend is relatively stagnant and IBDR is experiencing slight selling pressure.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $33.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.
IBDR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 50.16 | Buy |
| Chaikin Money Flow: | -544938 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.03 - 24.11) | Sell |
| Bollinger Bands (100): | (24.07 - 24.21) | Sell |
COLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 66.05 | Buy |
| Chaikin Money Flow: | 1007158 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.9 - 30.94) | Buy |
| Bollinger Bands (100): | (30.52 - 37.92) | Sell |
IBDR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.06 | Buy |
| 20-day SMA: | 24.07 | Buy |
| 50-day SMA: | 24.08 | Sell |
| 200-day SMA: | 23.98 | Buy |
| 8-day EMA: | 24.06 | Buy |
| 20-day EMA: | 24.07 | Buy |
| 50-day EMA: | 24.09 | Sell |
| 200-day EMA: | 24 | Buy |
COLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.45 | Buy |
| 20-day SMA: | 29.79 | Buy |
| 50-day SMA: | 30.91 | Buy |
| 200-day SMA: | 34.47 | Sell |
| 8-day EMA: | 30.02 | Buy |
| 20-day EMA: | 29.94 | Buy |
| 50-day EMA: | 31.21 | Buy |
| 200-day EMA: | 32.94 | Buy |
iShares iBonds Dec 2026 Term Corporate ETF Earnings Growth & IBDR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.
iShares iBonds Dec 2026 Term Corporate ETF Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Collegium Pharmaceutical Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||